Literature DB >> 12458200

Aurora-B regulates the cleavage furrow-specific vimentin phosphorylation in the cytokinetic process.

Hidemasa Goto1, Yoshihiro Yasui, Aie Kawajiri, Erich A Nigg, Yasuhiko Terada, Masaaki Tatsuka, Koh-ichi Nagata, Masaki Inagaki.   

Abstract

Aurora-B is an evolutionally conserved protein kinase that regulates several mitotic events including cytokinesis. We previously demonstrated the possible existence of a protein kinase that phosphorylates at least Ser-72 on vimentin, the most widely expressed intermediate filament protein, in the cleavage furrow-specific manner. Here we showed that vimentin-Ser-72 phosphorylation occurred specifically at the border of the Aurora-B-localized area from anaphase to telophase. Expression of a dominant-negative mutant of Aurora-B led to a reduction of this vimentin-Ser-72 phosphorylation. In vitro analyses revealed that Aurora-B phosphorylates vimentin at approximately 2 mol phosphate/mol of substrate for 30 min and that this phosphorylation dramatically inhibits vimentin filament formation. We further identified eight Aurora-B phosphorylation sites, including Ser-72 on vimentin, and then constructed the mutant vimentin in which these identified sites are changed into Ala. Cells expressing this mutant formed an unusually long bridge-like intermediate filament structure between unseparated daughter cells. We then identified important phosphorylation sites for the bridge phenotype. Our findings indicate that Aurora-B regulates the cleavage furrow-specific vimentin phosphorylation and controls vimentin filament segregation in cytokinetic process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458200     DOI: 10.1074/jbc.M210892200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

Review 2.  Chromosomal passengers: the four-dimensional regulation of mitotic events.

Authors:  Paola Vagnarelli; William C Earnshaw
Journal:  Chromosoma       Date:  2004-09-04       Impact factor: 4.316

Review 3.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

4.  Aurora B interaction of centrosomal Nlp regulates cytokinesis.

Authors:  Jie Yan; Shunqian Jin; Jia Li; Qimin Zhan
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

5.  Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property.

Authors:  Hao G Nguyen; Dharmaraj Chinnappan; Takeshi Urano; Katya Ravid
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

6.  Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP.

Authors:  Ulf R Klein; Erich A Nigg; Ulrike Gruneberg
Journal:  Mol Biol Cell       Date:  2006-03-29       Impact factor: 4.138

Review 7.  The sweet side of the cell cycle.

Authors:  Ee Phie Tan; Francesca E Duncan; Chad Slawson
Journal:  Biochem Soc Trans       Date:  2017-04-15       Impact factor: 5.407

Review 8.  Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.

Authors:  Ram K Sihag; Masaki Inagaki; Tomoya Yamaguchi; Thomas B Shea; Harish C Pant
Journal:  Exp Cell Res       Date:  2007-04-12       Impact factor: 3.905

9.  A vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers.

Authors:  Michael J Bollong; Mika Pietilä; Aaron D Pearson; Tapasree Roy Sarkar; Insha Ahmad; Rama Soundararajan; Costas A Lyssiotis; Sendurai A Mani; Peter G Schultz; Luke L Lairson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

Review 10.  Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.

Authors:  Katalin Hegyi; Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2012-07-29       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.